C-MER Eye Care Holdings Limited

HKSE 3309.HK

C-MER Eye Care Holdings Limited Revenue Per Share for the year ending December 31, 2023: USD 0.20

C-MER Eye Care Holdings Limited Revenue Per Share is USD 0.20 for the year ending December 31, 2023, a 9.13% change year over year. Revenue per share indicates revenue generated per share; higher ratios suggest stronger performance and value.

C-MER Eye Care Holdings Limited Revenue Per Share for the year ending December 31, 2022 was USD 0.18, a 44.70% change year over year.
C-MER Eye Care Holdings Limited Revenue Per Share for the year ending December 31, 2021 was USD 0.12, a 52.09% change year over year.
C-MER Eye Care Holdings Limited Revenue Per Share for the year ending December 31, 2020 was USD 0.08, a 15.61% change year over year.
C-MER Eye Care Holdings Limited Revenue Per Share for the year ending December 31, 2019 was USD 0.07, a 31.80% change year over year.

Key data

Date	Revenue Per Share	Dividend Per Share	Free Cash Flow Per Share	Return on Assets (ROA)

HKSE: 3309.HK

C-MER Eye Care Holdings Limited

CEO	Dr. Shun Chiu Lam J.P.
IPO Date	Jan. 15, 2018
Location	Hong Kong
Headquarters	Central Building
Employees	2,192
Sector	Consumer Discretionary
Industries Eyewear Cosmetics Pharmaceuticals

Description

C-MER Eye Care Holdings Limited, an investment holding company, provides ophthalmic services under the C-MER Dennis Lam brand name in Hong Kong and Mainland China. The company operates eye and surgery centers, and satellite clinics that provide cataract and intraocular lens implant, refractive correction, corneal and external eye disease, glaucoma, vitreo-retinal disease, oculoplastic and orbital disease, and squint and pediatric ophthalmology services. It also sells vision aid and pharmaceutical products, as well as dental services. The company was founded in 2012 and is headquartered in Central, Hong Kong. C-MER Eye Care Holdings Limited is a subsidiary of C-MER Group Limited.

Key trends

Past 5 years